ADA Forsyth Institute, Inc.

ADA Forsyth Institute, Inc. (doing business as The Forsyth Institute), a nonprofit biomedical research organization headquartered in Cambridge, Massachusetts, is a federal grant recipient conducting investigator-initiated basic and translational research in oral diseases, periodontal health, oral microbiome ecology, salivary gland dysfunction, and craniofacial development. The institute operates exclusively in the federal research grant space as a prime recipient and sub-recipient; it does not hold federal contracts or contract vehicles.

The National Institute of Dental and Craniofacial Research (NIDCR) is the dominant funding source, accounting for approximately 80 of the institute's 175 total awards and representing about 86 percent of awards by count. The institute's capability portfolio centers on investigator-initiated research spanning oral microbiome characterization using next-generation sequencing and imaging, host-microbe interactions at the cellular and molecular level, mechanisms of periodontal disease and salivary gland dysfunction in autoimmune disease, dental materials innovation, craniofacial bone regeneration, and oral cancer biology. Recent representative prime awards include a $629,029 NIDCR Project Grant (awarded September 2026, running through May 2031) investigating therapeutic mechanisms linking gut microbiota and salivary gland function in Sjögren's syndrome; a $706,281 NIDCR Project Grant (awarded May 2026, running through April 2031) examining microRNA-mediated mechanisms in temporomandibular joint health and disease; a $398,000 NIDCR Project Grant (awarded July 2025, running through July 2027) on mechanistic investigation of bacterial species interactions in clear aligner-induced periodontal inflammation; and a Forsyth Student Scholars summer internship program (NIDCR, awarded December 2024, running through November 2029) preparing underrepresented high school students for science and oral health research careers.

Activity has grown substantially over the past five years—from five awards in 2022 to twenty-two in 2024—with a recent deceleration to eight awards in 2026 year-to-date. Twelve awards face ultimate completion within the next twenty-four months, presenting recompete opportunity across the institute's research portfolio. The broader federal customer base includes the National Institute of Allergy and Infectious Diseases, the National Institute of Neurological Disorders and Stroke, the National Institute of Environmental Health Sciences, the Health Resources and Services Administration, and the National Cancer Institute, though NIDCR dominates both award count and funding volume.

In its sub-recipient role, the institute partners with universities and research hospitals across multiple NIH-funded projects as a collaborating investigator or core facility provider. Representative sub-awards include roles at the University of Kentucky on recruit and sampling collection for periodontal disease research, at Wake Forest University Health Sciences on bioengineering and tissue-specific fluorophore design for bone scaffold development, at the University of Florida on characterization of outer-membrane vesicle components from oral bacteria, at Tufts University on oral microbiome and immunology guidance, and at Harvard's dental school on tooth enamel sampling strategy and analysis. The institute also houses advanced microscopy and cell culture core facilities supporting collaborative research from external principal investigators.

The institute's awards carry combined potential value of $364 thousand across prime and sub engagements, with $275.4 million in combined dollars obligated—a ratio reflecting the mature, multi-year nature of investigator-initiated NIH research grants. The portfolio is concentrated in basic research and translational research in biotechnology and health sciences; no federal contract work is present.